Sawleshwarkar Shailendra, Harrison Christopher, Britt Helena, Mindel Adrian
Sexually Transmitted Infections Research Centre and University of Sydney, Marian Villa, Westmead Hospital, Westmead, NSW 2145, Australia.
Sex Health. 2010 Dec;7(4):484-90. doi: 10.1071/SH09110.
We aimed to ascertain how frequently Australian general practitioners (GPs) test patients for chlamydia and to determine GP, patient and encounter characteristics where tests occurred.
We identified all GP, patient and encounter characteristics associated with higher testing rates, April 2000 to March 2007, using the Bettering the Evaluation and Care of Health data. Multiple logistic regression was used to measure the effect of each GP, patient and encounter characteristic.
Data were available for 689 000 encounters from 6890 GPs, of which 2236 were test encounters. Testing rates increased significantly between 2000 and 2007 (P < 0.0001). The rate of testing was higher for female patients (4.2 per 1000, 95% confidence interval (CI): 3.8-4.5) than males (2.0; 95% CI: 1.8-2.2). Predictors of higher chlamydia testing were: female GP (adjusted odds ratio (AOR): 1.84; 95% CI: 1.60-2.1); GP age (<35 v. 55+, 2.17; 95% CI: 1.65-2.85); practice in a major city (1.34; 95% CI: 1.18-1.52); large practice (5+ GP practice v. solo, 1.69; 95% CI: 1.27-2.25); graduated in Australia (1.22; 95% CI: 1.04-1.44); patient sex and younger age, being new to the practice (1.65; 95% CI: 0.47-1.86), Indigenous (3.46; 95% CI: 2.64-4.54), late in the study (twice as likely in 2006-07 than in 2000-01) and 'opportunity to test' (AOR: 32.25; 95% CI: 27.25-38.16).
Chlamydia testing rates have increased in general practice in Australia, with higher rates in females. Initiatives to overcome barriers to testing (especially for male patients and older male GPs) need to be established and evaluated.
我们旨在确定澳大利亚全科医生(GP)对患者进行衣原体检测的频率,并确定进行检测时的全科医生、患者及诊疗情况特征。
我们利用改善健康评估与照护数据,确定了2000年4月至2007年3月期间与较高检测率相关的所有全科医生、患者及诊疗情况特征。采用多重逻辑回归来衡量每个全科医生、患者及诊疗情况特征的影响。
获得了来自6890名全科医生的689000次诊疗数据,其中2236次为检测诊疗。2000年至2007年期间检测率显著上升(P < 0.0001)。女性患者的检测率(每1000人中有4.2人,95%置信区间(CI):3.8 - 4.5)高于男性(2.0;95% CI:1.8 - 2.2)。衣原体检测率较高的预测因素包括:女性全科医生(调整优势比(AOR):1.84;95% CI:1.60 - 2.1);全科医生年龄(<35岁对比55岁及以上,2.17;95% CI:1.65 - 2.85);在大城市执业(1.34;95% CI:1.18 - 1.52);大型诊所(5名及以上全科医生的诊所对比单人诊所,1.69;95% CI:1.27 - 2.25);在澳大利亚毕业(1.22;95% CI:1.04 - 1.44);患者性别及较年轻年龄、新到该诊所就诊(1.65;95% CI:0.47 - 1.86)、原住民(3.46;95% CI:2.64 - 4.54)、研究后期(2006 - 2007年的可能性是2000 - 2001年的两倍)以及“检测机会”(AOR:32.25;95% CI:27.25 - 38.16)。
澳大利亚全科医疗中衣原体检测率有所上升,女性检测率更高。需要制定并评估克服检测障碍的举措(尤其是针对男性患者和年长男性全科医生)。